Capricor Therapeutics and Parents Project Muscular Dystrophy to Host Webinar to Discuss Interim Analysis of the HOPE-2 Clinical Trial to Treat Patients with Duchenne Muscular Dystrophy
Stock Information for Capricor Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.